Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeNASDAQ:VRTX

      NASDAQ:VRTX

      Vertex Initiates NDA Filing Rollout for Acute Pain Medication
      Investing News

      Vertex Initiates NDA Filing Rollout for Acute Pain Medication

      April 19, 2024
      Vertex Pharmaceuticals Advances Kidney Disease Drug to Phase 3 Development
      Investing News

      Vertex Pharmaceuticals Advances Kidney Disease Drug to Phase 3 Development

      April 2, 2024
      Vertex Pharmaceuticals Advances Kidney Disease Drug into Clinical Trials
      Investing News

      Vertex Pharmaceuticals Advances Kidney Disease Drug into Clinical Trials

      March 22, 2024

       

      LATEST NEWS

      • Investing News RPM’s Economic and Weather Challenges
      • Investing News Investment Insights on Top Stocks
      • Investing News Stellantis Reports 68-Year Low in Production
      • Investing News Top Quantum Computing Stocks to Watch
      • Investing News Rivian Achieves 2024 Production Goal

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026